Zai Lab Announces Launch of Optune in Hong Kong for Patients with Glioblastoma Multiforme

Zai Lab  today announced the launch of Optune (Tumor Treating Fields or TTFields) in Hong Kong ...

January 1, 2019 | Tuesday | News
BeiGene initiates clinical trial of Tislelizumab with cancer patients

BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecul...

December 31, 2018 | Monday | News
Luye Pharma’s innovative drug enters final stage of NDA Process

Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovativ...

December 31, 2018 | Monday | News
OUE Lippo's JV to manage three medical facilities in China

Singapore – OUE Lippo Healthcare Limited announced that its 50:50 joint venture company with China Merch...

December 31, 2018 | Monday | News
InventisBio, Betta Pharma collaborate for Non-Small Cell Lung Cancer drug

InventisBio announced that it has signed a "Collaboration Agreement" with Betta Pharma.  Under this agreement, Inve...

December 28, 2018 | Friday | News
MEDI FUTURES raises US$5M through common stocks

MEDI FUTURES, a biomedical ultrasound company and a member company of the K-ICT Born2Global Centre, successfully at...

December 28, 2018 | Friday | News
JHL Biotech declares Phase III Study of JHL1101

JHL Biotech announced today that the first patient at Beijing Cancer Hospital has been successfully randomized in t...

December 28, 2018 | Friday | News
Innovent, Eli Lilly announce co-development of Tyvyt

Innovent Biologics and Eli Lilly and Company have jointly announced that the co-developed Tyvyt (fully human anti-PD-1 t...

December 28, 2018 | Friday | News
ICSE China 2019 helps enterprises seize new industry opportunities

ICSE China 2019, hosted by CCCMHPIE, UBM EMEA, and UBM Sinoexpo, will take place again in Hall E2/E7...

December 27, 2018 | Thursday | News
Xynomic Pharma acquires global exclusive rights for Boehringer Ingelheim's cancer drug

Xynomic Pharmaceuticals, Inc., a clinical stage US-China oncology drug development company has announced that it has bee...

December 26, 2018 | Wednesday | News
I-Mab gets UDFDA IND nod for exclusive monoclonal antibody TJM2

I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company exclusively focused on the developm...

December 24, 2018 | Monday | Company results
Xynomic acquires cancer candidate from Boehringer for $800 M

Xynomic Pharmaceuticals, Inc., a clinical stage US-China oncology drug development company, has been granted an exclusiv...

December 21, 2018 | Friday | News
Gan & Lee enters into licensing agreement for insulin analogs

Gan & Lee Pharmaceuticals (Gan & Lee), an industry leading biopharmaceutical company with 20 years’ experi...

December 20, 2018 | Thursday | News
Align reaches 6M Invisalign patient milestone from China

Singapore - Align Technology announced that over 6 million patients have begun treatment with Invisalign - the most...

December 19, 2018 | Wednesday | News
Pall opens Biotech integrated solutions Centre in China

Pall Corporation, the global leader of advanced filtration, separation and purification technologies, has established a ...

December 19, 2018 | Wednesday | News
Cellular Biomedicine Group Appoints CAR-T Pioneer as Member of Scientific Advisory Board

  Cellular Biomedicine Group, a biopharmaceutical firm engaged in the development of immunothera...

December 18, 2018 | Tuesday | News
FibroGen's roxadustat OK'd in China

Singapore – China's National Medical Products Administration approves FibroGen's roxadustat, a hypoxia-i...

December 18, 2018 | Tuesday | News
2019 ENMORE BIO CONFERENCE set to host biotech industry in China

Singapore - 2019 ENMORE BIO CONFERENE will be held on 1st-3rd, March, 2019 in Nanjing Young Cultural Center, Nanjing, Ch...

December 18, 2018 | Tuesday | News